Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 28;25(1):436.
doi: 10.1186/s12879-025-10832-7.

Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review

Sipang Pangprasertkul  1 , Nida Buawangpong  2   3 , Kanokporn Pinyopornpanish  4   5 , Wichuda Jiraporncharoen  4   5 , Chaisiri Angkurawaranon  4   5
Affiliations

Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review

Sipang Pangprasertkul et al. BMC Infect Dis. .

Abstract

Background: Children and adolescents are at increased risk of progressing from latent to active tuberculosis (TB). The 3-month, once-weekly isoniazid and rifapentine (3HP) regimen offers a shorter tuberculosis preventive treatment (TPT) option. However, evidence regarding its completion rates and safety in these populations remains limited.

Objective: To evaluate treatment completion rates and adverse events associated with the 3HP regimen in children and adolescents.

Methods: A systematic review of studies evaluated the 3HP regimen in children and adolescents with LTBI was conducted. Databases including PubMed, Embase, Cochrane Library, and CINAHL were searched to identify relevant studies. Data on treatment completion rates and adverse events were extracted and analyzed descriptively.

Results: Ten studies involving children and adolescents aged 0-20 years were reviewed. Treatment completion rates were higher with 3HP regimen ranged from 70.9 to 100%, with a favorable safety profile. Mild adverse events, including nausea, vomiting, and abdominal pain, were reported, with no serious adverse events or hepatotoxicity observed.

Conclusions: The 3HP regimen demonstrates high completion rates and safety profile in children and adolescents with LTBI, highlighting its suitability for this population. Expanding its implementation in programmatic settings is crucial to advancing global TB elimination.

Keywords: 3HP; Children and adolescents; Latent tuberculosis infection; Rifapentine and Isoniazid; Tuberculosis preventive treatment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethic approval and consent to participate: Not applicable. This systematic review involves no direct human or animal subjects, and only involves the analysis of published data. Clinical trial: Not applicable. Consent for publication: Not applicable. This article does not contain any individual person’s data in any form. Conflict of interest: None declared.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of screening and selection processes
See this image and copyright information in PMC

References

    1. Jenkins HE. Global burden of childhood tuberculosis. Pneumonia (Nathan). 2016;8:24. - PMC - PubMed
    1. Global tuberculosis report 2024. Geneva: World Health Organization; 2024.
    1. Cohen A, Mathiasen VD, Schön T, et al. The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2019;54:1900655. - PubMed
    1. Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PloS Med. 2016. - PMC - PubMed
    1. WHO consolidated guidelines. On tuberculosis: tuberculosis preventive treatment. Geneva: World Health Organization; 2020. - PubMed

Publication types

MeSH terms

LinkOut - more resources